Herrman H, Kieling C, McGorry P, Horton R, Sargent J, Patel V. Reducing the global burden of depression: a Lancet-World Psychiatric Association Commission. Lancet. 2019;393(10189):e42–3.
Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2007;164(8):1198–205.
Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, Stein DJ, Zaslavsky AM, Aguilar-Gaxiola S, Alonso J, et al. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry. 2011;68(1):90–100.
Article PubMed PubMed Central Google Scholar
Liao SC, Chen WJ, Lee MB, Lung FW, Lai TJ, Liu CY, Lin CY, Yang MJ, Chen CC. Low prevalence of major depressive disorder in Taiwanese adults: possible explanations and implications. Psychol Med. 2012;42(6):1227–37.
Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155–62.
Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the national epidemiologic survey on Alcoholism and related conditions. Arch Gen Psychiatry. 2005;62(10):1097–106.
Insel TR, Charney DS. Research on major depression: strategies and priorities. JAMA. 2003;289(23):3167–8.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey replication (NCS-R). JAMA. 2003;289(23):3095–105.
Lépine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3–7.
PubMed PubMed Central Google Scholar
Godbout JP, Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol. 2006;1(4):421–7.
Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol. 2002;53:83–107.
Almeida OP, Norman P, Hankey GJ, Jamrozik K, Flicker L. The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in men Study (HIMS). Psychol Med. 2007;37(12):1775–86.
Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008;106(3):249–55.
Article CAS PubMed Google Scholar
May M, Klein SR. Differential diagnosis of facial nerve Palsy. Otolaryngol Clin North Am. 1991;24(3):613–45.
Article CAS PubMed Google Scholar
Zandian A, Osiro S, Hudson R, Ali IM, Matusz P, Tubbs SR, Loukas M. The neurologist’s dilemma: a comprehensive clinical review of Bell’s palsy, with emphasis on current management trends. Med Sci Monit. 2014;20:83–90.
Article PubMed PubMed Central Google Scholar
Holland NJ, Weiner GM. Recent developments in Bell’s palsy. BMJ. 2004;329(7465):553–7.
Article PubMed PubMed Central Google Scholar
Gilden DH. Clinical practice. Bell’s Palsy. N Engl J Med. 2004;351(13):1323–31.
Article CAS PubMed Google Scholar
Eviston TJ, Croxson GR, Kennedy PG, Hadlock T, Krishnan AV. Bell’s palsy: aetiology, clinical features and multidisciplinary care. J Neurol Neurosurg Psychiatry. 2015;86(12):1356–61.
Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M. Bell’s palsy and autoimmunity. Autoimmun Rev. 2012;12(2):323–8.
Article CAS PubMed Google Scholar
Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK, Peleg AY. The benefits of steroids versus steroids plus antivirals for treatment of Bell’s palsy: a meta-analysis. BMJ. 2009;339:b3354.
Article PubMed PubMed Central Google Scholar
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–57.
Article CAS PubMed Google Scholar
Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135(5):373–87.
Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012;139(3):230–9.
Article CAS PubMed Google Scholar
Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–41.
Article CAS PubMed PubMed Central Google Scholar
Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun. 2009;23(7):936–44.
Article CAS PubMed PubMed Central Google Scholar
Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, et al. Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry. 2019;214(1):11–9.
Article PubMed PubMed Central Google Scholar
Pitharouli MC, Hagenaars SP, Glanville KP, Coleman JRI, Hotopf M, Lewis CM, Pariante CM. Elevated C-Reactive protein in patients with Depression, Independent of Genetic, Health, and psychosocial factors: results from the UK Biobank. Am J Psychiatry. 2021;178(6):522–9.
Sforzini L, Cattaneo A, Ferrari C, Turner L, Mariani N, Enache D, Hastings C, Lombardo G, Nettis MA, Nikkheslat N, et al. Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study. Translational Psychiatry. 2023;13(1):185.
Article CAS PubMed PubMed Central Google Scholar
Yilmaz M, Tarakcioglu M, Bayazit N, Bayazit YA, Namiduru M, Kanlikama M. Serum cytokine levels in Bell’s palsy. J Neurol Sci. 2002;197(1–2):69–72.
Article CAS PubMed Google Scholar
Cayir S, Hizli O, Kayabasi S. Is C-reactive protein to albumin ratio an indicator of poor prognosis in Bell’s palsy? Eur Arch Otorhinolaryngol. 2020;277(1):115–9.
Tseng CC, Hu LY, Liu ME, Yang AC, Shen CC, Tsai SJ. Bidirectional association between Bell’s palsy and anxiety disorders: a nationwide population-based retrospective cohort study. J Affect Disord. 2017;215:269–73.
Żmudzka E, Sałaciak K, Sapa J, Pytka K. Serotonin receptors in depression and anxiety: insights from animal studies. Life Sci. 2018;210:106–24.
Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci. 2016;17(8):524–32.
Article CAS PubMed PubMed Central Google Scholar
de la Mora MP, Gallegos-Cari A, Arizmendi-García Y, Marcellino D, Fuxe K. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog Neurobiol. 2010;90(2):198–216.
Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234–56.
Article CAS PubMed PubMed Central Google Scholar
Yuan B, Li W, Liu H, Cai X, Song S, Zhao J, Hu X, Li Z, Chen Y, Zhang K, et al. Correlation between immune response and self-reported depression during convalescence from COVID-19. Brain Behav Immun. 2020;88:39–43.
Article CAS PubMed PubMed Central Google Scholar
Abramsky O, Webb C, Teitelbaum D, Arnon R. Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell’s palsy). J Neurol Sci. 1975;26(1):13–20.
留言 (0)